Theralase Technologies Stock Price History
| TLT Stock | CAD 0.28 0.01 3.70% |
Below is the normalized historical share price chart for Theralase Technologies extending back to August 20, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Theralase Technologies stands at 0.28, as last reported on the 1st of February, with the highest price reaching 0.28 and the lowest price hitting 0.27 during the day.
If you're considering investing in Theralase Stock, it is important to understand the factors that can impact its price. Theralase Technologies appears to be out of control, given 3 months investment horizon. Theralase Technologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0523, which indicates the firm had a 0.0523 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Theralase Technologies, which you can use to evaluate the volatility of the company. Please review Theralase Technologies' Semi Deviation of 5.97, risk adjusted performance of 0.0515, and Coefficient Of Variation of 1955.8 to confirm if our risk estimates are consistent with your expectations.
At this time, Theralase Technologies' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to climb to about 265.6 M in 2025, whereas Common Stock is likely to drop slightly above 29.7 M in 2025. . Price To Sales Ratio is likely to drop to 40.42 in 2025. Price Earnings Ratio is likely to climb to -9.46 in 2025. Theralase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.1916 | 50 Day MA 0.2176 | Beta 1.349 |
Theralase |
Sharpe Ratio = 0.0523
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TLT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.22 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Theralase Technologies is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theralase Technologies by adding it to a well-diversified portfolio.
Price Book 31.8562 | Enterprise Value Ebitda (12.06) | Price Sales 74.0147 | Shares Float 226 M | Wall Street Target Price 1.2 |
Theralase Technologies Stock Price History Chart
There are several ways to analyze Theralase Stock price data. The simplest method is using a basic Theralase candlestick price chart, which shows Theralase Technologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 0.31 |
| Lowest Price | November 28, 2024 | 0.21 |
Theralase Technologies February 1, 2025 Stock Price Synopsis
Various analyses of Theralase Technologies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Theralase Stock. It can be used to describe the percentage change in the price of Theralase Technologies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Theralase Stock.| Theralase Technologies Price Action Indicator | 0.01 | |
| Theralase Technologies Price Rate Of Daily Change | 1.04 | |
| Theralase Technologies Price Daily Balance Of Power | 1.00 |
Theralase Technologies February 1, 2025 Stock Price Analysis
Theralase Stock Price History Data
The price series of Theralase Technologies for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 0.1 with a coefficient of variation of 7.19. The price distribution for the period has arithmetic mean of 0.27. The median price for the last 90 days is 0.27. The company had dividends distributed to its stock-holders on Feb 1, 2011.| Open | High | Low | Close | Volume | ||
02/01/2025 | 0.28 | 0.28 | 0.27 | 0.28 | ||
| 01/31/2025 | 0.28 | 0.28 | 0.27 | 0.28 | 103,608 | |
| 01/30/2025 | 0.27 | 0.28 | 0.27 | 0.28 | 20,000 | |
| 01/29/2025 | 0.28 | 0.28 | 0.26 | 0.27 | 93,078 | |
| 01/28/2025 | 0.26 | 0.28 | 0.26 | 0.28 | 367,500 | |
| 01/27/2025 | 0.25 | 0.26 | 0.25 | 0.25 | 209,695 | |
| 01/24/2025 | 0.26 | 0.26 | 0.25 | 0.25 | 124,200 | |
| 01/23/2025 | 0.27 | 0.27 | 0.26 | 0.27 | 44,254 | |
| 01/22/2025 | 0.28 | 0.28 | 0.27 | 0.27 | 51,540 | |
| 01/21/2025 | 0.28 | 0.28 | 0.27 | 0.27 | 37,100 | |
| 01/20/2025 | 0.28 | 0.28 | 0.26 | 0.28 | 54,300 | |
| 01/17/2025 | 0.28 | 0.28 | 0.27 | 0.27 | 130,624 | |
| 01/16/2025 | 0.26 | 0.27 | 0.26 | 0.26 | 27,750 | |
| 01/15/2025 | 0.28 | 0.28 | 0.27 | 0.27 | 67,171 | |
| 01/14/2025 | 0.30 | 0.30 | 0.27 | 0.28 | 173,310 | |
| 01/13/2025 | 0.29 | 0.31 | 0.29 | 0.29 | 58,315 | |
| 01/10/2025 | 0.30 | 0.30 | 0.29 | 0.30 | 41,605 | |
| 01/09/2025 | 0.30 | 0.31 | 0.30 | 0.31 | 41,500 | |
| 01/08/2025 | 0.31 | 0.31 | 0.29 | 0.30 | 134,370 | |
| 01/07/2025 | 0.32 | 0.32 | 0.31 | 0.31 | 47,777 | |
| 01/06/2025 | 0.29 | 0.34 | 0.29 | 0.31 | 452,563 | |
| 01/03/2025 | 0.28 | 0.29 | 0.28 | 0.29 | 104,376 | |
| 01/02/2025 | 0.27 | 0.30 | 0.27 | 0.28 | 146,027 | |
| 12/31/2024 | 0.26 | 0.27 | 0.26 | 0.27 | 47,000 | |
| 12/30/2024 | 0.25 | 0.25 | 0.25 | 0.25 | 20,000 | |
| 12/27/2024 | 0.25 | 0.26 | 0.24 | 0.26 | 33,774 | |
| 12/24/2024 | 0.25 | 0.26 | 0.24 | 0.26 | 17,500 | |
| 12/23/2024 | 0.26 | 0.26 | 0.24 | 0.25 | 82,195 | |
| 12/20/2024 | 0.28 | 0.28 | 0.23 | 0.25 | 287,012 | |
| 12/19/2024 | 0.27 | 0.28 | 0.27 | 0.27 | 15,600 | |
| 12/18/2024 | 0.27 | 0.27 | 0.27 | 0.27 | 24,657 | |
| 12/17/2024 | 0.26 | 0.28 | 0.26 | 0.27 | 80,345 | |
| 12/16/2024 | 0.25 | 0.26 | 0.25 | 0.26 | 23,000 | |
| 12/13/2024 | 0.26 | 0.26 | 0.25 | 0.26 | 58,673 | |
| 12/12/2024 | 0.26 | 0.27 | 0.25 | 0.26 | 20,290 | |
| 12/11/2024 | 0.27 | 0.27 | 0.27 | 0.27 | 1.00 | |
| 12/10/2024 | 0.27 | 0.27 | 0.26 | 0.27 | 42,300 | |
| 12/09/2024 | 0.25 | 0.26 | 0.25 | 0.26 | 81,600 | |
| 12/06/2024 | 0.27 | 0.28 | 0.26 | 0.26 | 85,278 | |
| 12/05/2024 | 0.27 | 0.28 | 0.27 | 0.28 | 116,666 | |
| 12/04/2024 | 0.25 | 0.28 | 0.25 | 0.27 | 141,781 | |
| 12/03/2024 | 0.25 | 0.25 | 0.24 | 0.24 | 12,447 | |
| 12/02/2024 | 0.23 | 0.25 | 0.23 | 0.25 | 254,500 | |
| 11/29/2024 | 0.22 | 0.23 | 0.21 | 0.22 | 221,413 | |
| 11/28/2024 | 0.28 | 0.28 | 0.20 | 0.21 | 843,900 | |
| 11/27/2024 | 0.30 | 0.30 | 0.29 | 0.30 | 64,200 | |
| 11/26/2024 | 0.28 | 0.30 | 0.28 | 0.30 | 30,710 | |
| 11/25/2024 | 0.30 | 0.30 | 0.28 | 0.28 | 44,300 | |
| 11/22/2024 | 0.30 | 0.30 | 0.29 | 0.30 | 18,000 | |
| 11/21/2024 | 0.29 | 0.29 | 0.28 | 0.29 | 25,000 | |
| 11/20/2024 | 0.29 | 0.29 | 0.28 | 0.28 | 11,000 | |
| 11/19/2024 | 0.28 | 0.28 | 0.27 | 0.28 | 24,500 | |
| 11/18/2024 | 0.27 | 0.29 | 0.27 | 0.28 | 119,900 | |
| 11/15/2024 | 0.28 | 0.30 | 0.28 | 0.28 | 118,900 | |
| 11/14/2024 | 0.28 | 0.30 | 0.28 | 0.28 | 34,000 | |
| 11/13/2024 | 0.29 | 0.29 | 0.28 | 0.28 | 38,726 | |
| 11/12/2024 | 0.32 | 0.32 | 0.27 | 0.27 | 269,276 | |
| 11/11/2024 | 0.29 | 0.32 | 0.29 | 0.31 | 54,000 | |
| 11/08/2024 | 0.28 | 0.29 | 0.27 | 0.29 | 39,369 | |
| 11/07/2024 | 0.26 | 0.28 | 0.26 | 0.28 | 43,900 | |
| 11/06/2024 | 0.26 | 0.26 | 0.25 | 0.26 | 120,000 |
About Theralase Technologies Stock history
Theralase Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theralase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theralase Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theralase Technologies stock prices may prove useful in developing a viable investing in Theralase Technologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 253 M | 265.6 M | |
| Net Loss | -4.7 M | -4.9 M |
Theralase Technologies Quarterly Net Working Capital |
|
Theralase Technologies Stock Technical Analysis
Theralase Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Theralase Technologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theralase Technologies' price direction in advance. Along with the technical and fundamental analysis of Theralase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theralase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0515 | |||
| Jensen Alpha | 0.2874 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | 0.0262 | |||
| Treynor Ratio | 1.35 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.